BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it will have a poster ...

today announces that it will have a poster presentation on 303 Study, the investigator-initiated study supported by Merck (known as MSD outside of the United States and Canada) and BeyondSpring in ...

today announces that it will have a poster presentation on 303 Study, the investigator-initiated study supported by Merck (known as MSD outside of the United States and Canada) and BeyondSpring in ...

NEWTON, Mass., May 14, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced its abstract ...

LCGC International provides separation science insights, including liquid chromatography (HPLC), gas chromatography (GC), and ...

From scholarly lectures to TED-style talks, from academic posters to interactive workshops ... and societal spheres. Here is a small sample of their recent work, showcasing the breadth and depth of ...

to respond favorably to olutasidenib, although the sample sizes are small for some co-mutations. Presenter: Andrew H. Wei, MBBS, Ph.D. In a separate cohort (n=18) of the Phase 2 trial ...

Fourth graders. They are usually around the age of 10. Their interests can vary, ranging from being on social media sites to ...

For a while, the footballers developed at English clubs were considered inferior. But no longer. What has changed?

The poster presentation, based on a post-hoc analysis of the 96-week ... but after 96 weeks it was similar. For example, qFibrosis® analysis of Week 96 biopsy samples from 50mg EFX patients (N=26) ...